LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
LBRX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.10B
- P/E (TTM)
- 341.60
- EPS (TTM)
- $0.10
- Dividend yield
- None
- 52-week range
- 14.32 – 50.16
- Day range
- 34.01 – 36.57
- Volume / Avg
- 385.03K / 339.93K
- Beta
- —
- Shares outstanding
- 32.26M
- Next earnings
- Nov 5, 2026
52-week range
LBRX stock today
On Oct 7, LBRX ended the session at $34.16, shedding $0.10 (0.29%), versus the S&P 500's 0.22% decline. At this level, LBRX sits in the middle of its 52-week range of $14.32 to $50.16: 31.9% below the high, set on Aug 25, 2026 and 138.6% above the low. LBRX is up 53.5% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 113.4%.
LB Pharmaceuticals trades at 341.6x its trailing twelve-month earnings per share of $0.10. LB Pharmaceuticals's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About LB Pharmaceuticals
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2025
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-1.61
LB Pharmaceuticals peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MNKDMannKind Corporation | 3.45 | -7.01% | $1.11B | vs LBRX |
| JANXJanux Therapeutics Inc. | 17.92 | +6.73% | $1.10B | vs LBRX |
| TRAXFirst Tracks Biotherapeutics Inc. | 30.59 | -2.55% | $1.09B | vs LBRX |
| BCAXBicara Therapeutics Inc. | 16.42 | -0.85% | $1.09B | vs LBRX |
| AMPHAmphastar Pharmaceuticals Inc. | 25.54 | -1.43% | $1.09B | vs LBRX |
| AVLNAvalyn Pharma Inc. | 25.53 | +0.39% | $1.13B | vs LBRX |
| HROWHarrow Inc. | 30.62 | +0.89% | $1.15B | vs LBRX |
| OPKOPKO Health Inc. | 1.39 | -4.79% | $1.04B | vs LBRX |
Indexes, lists and sector
LB Pharmaceuticals stock FAQ
What is LB Pharmaceuticals's stock price today?
LBRX last traded at $34.16 as of Oct 7, 4:00 PM EDT, down 0.29% on the day. Prices are delayed at least 15 minutes.
When is LB Pharmaceuticals's next earnings date?
LB Pharmaceuticals is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-1.61.
What is LBRX's P/E ratio?
LBRX trades at a trailing P/E ratio of 341.60.
What is the LBRX 52-week high?
The 52-week high for LBRX is $50.16 and the 52-week low is $14.32. The stock is currently 31.9% below its high.